Related Experiment Videos
[Apoptosis and human viral infections]
Abstract:
Homeostasis of cell numbers in tissues is maintained by a critical balance between cell proliferation and programmed cell death or apoptosis. Many human viruses are able to develop suitable strategies for modifying apoptosis in virus-infected cells and in virus-primed T cells. Apoptosis is characterized by the fragmentation of nuclear DNA into 180-200 bp apoptotic bodies and can be analysed microscopically or by flow cytometry using staining with various dyes. Moreover DNA cleavage can be identified by electrophoresis and by specific labeling using in situ nucleotidyltransferase assay (ISNT), terminal deoxynucleotidyltransferase-mediated dUTP nick-end labeling technique (Tunel), or by Elisa. Adenovirus E1A induces expression of protooncogenes c-myc and c-fos which sensitize cells to apoptosis; EBV EBNA-5, and adenovirus E1A, HPV E7, and polyomavirus large T act in the same way by displacing pRB-bound E2F. EBV EBNA-5, HPV E6, Adenovirus E1B 55 kDa inactivate the tumor suppressor protein p53 and engage the cells in the transformation process. EBV LMP-1, HHV6, and HTLV1 tax induce the antiapoptotic bcl-2 protein. EBV BHRF1 encodes proteins with homology to bcl-2 and Adenovirus E1B 19 kDa encodes proteins that have protective functions similar to bcl-2. Activated lymphocytes responding to viral infections express high levels of fas and are susceptible to apoptosis. TNF alpha can down- or up-regulate fas and down-regulates TNF-R. Adenovirus E1B 19 kDa blocks the proapoptotic activity of TNF alpha. Inversly, Cytomegalovirus, hepatitis C virus and Myxoviruses up-regulate fas antigen prior to undergoing apoptosis. In HIV-infected patients, CD4+ T-cell apoptosis is mediated by the cytopathic effect of the virus and the cell surface expression of gp 120-env protein. Moreover, an accelerated T-cell apoptosis in HIV-infected individuals is characterized by (i) HIV gp120-CD4+ cross-linking and subsequent aberrant signaling of T-cells, (ii) involvement of TNF alpha-fas/Apo-1 (TNF-R) binding, (iii) involvement of accessory cells as an apoptosis inducer and as a result of defective antigen presentation, (iv) possible superantigen activity induced by HIV products and cofactors. Many viruses also encode proteins with protease activity which could induce apoptosis. The induction of apoptosis may result in virus clearance, in contrast the inhibition of apoptosis may result in virus cell transformation and viral persistence. Indirectly, the apoptosis of infected cells may be induced by CTLs, NK cells and cytokines. In addition, apoptosis-mediated physiological depletion of T lymphocytes in the course of viral infection can silence the immune response and can induce immunodeficiency.
Insights
Viruses manipulate programmed cell death (apoptosis) to ensure their survival and replication. Understanding these viral strategies is key to developing effective antiviral therapies and combating viral diseases.
Area of Science:
- Molecular Biology
- Virology
- Immunology
Context:
- Cellular homeostasis relies on a balance between proliferation and apoptosis.
- Viruses have evolved mechanisms to interfere with apoptosis in host cells and immune cells.
- Apoptosis detection methods include DNA fragmentation analysis, flow cytometry, and specific labeling techniques.
Purpose:
- To review viral strategies for modulating apoptosis.
- To explore the role of apoptosis in viral infections and pathogenesis.
- To highlight the implications of apoptosis manipulation for viral persistence and host immunity.
Summary:
- Viruses employ diverse tactics to evade or induce apoptosis, involving viral proteins that target key apoptotic regulators like p53 and Bcl-2.
- Specific viruses like Adenovirus, EBV, HPV, and HIV utilize distinct proteins (e.g., E1A, EBNA-5, E6, gp120) to disrupt apoptotic pathways.
- Viral modulation of apoptosis impacts T-cell activation, immune responses, and can lead to viral persistence, transformation, or immunodeficiency.
Impact:
- Insights into viral apoptosis manipulation can inform the development of novel antiviral therapies.
- Understanding these mechanisms is crucial for managing viral infections and their associated pathologies.
- This knowledge contributes to a deeper understanding of host-pathogen interactions and immune evasion strategies.